RNA-Binding Proteins as a Molecular Link between COPD and Lung Cancer

References

• Barnes PJ, Adcock IM. Chronic obstructive pulmonary disease and lung cancer: a lethal association. Am J Respir Crit Care Med. 2011;184(8):866–867. DOI:10.1164/rccm.201108-1436ED
   PubMed Web of Science ®Google Scholar
• Barreiro E, Fermoselle C, Mateu-Jimenez M, et al. Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD. Free Radic Biol Med. 2013;65:859–871. DOI:10.1016/j.freeradbiomed.2013.08.006
   PubMed Web of Science ®Google Scholar
• Durham AL, Adcock IM. The relationship between COPD and lung cancer. Lung Cancer. 2015;90(2):121–127. DOI:10.1016/j.lungcan.2015.08.017
   PubMed Web of Science ®Google Scholar
• Nucera F, Mumby S, Paudel KR, Dharwal V, Di Stefano A, Casolaro V, Hansbro PM, Adcock IM, Caramori G. Role of oxidative stress in the pathogenesis of COPD. Minerva Med. 2022;113(3):370–404. DOI:10.23736/S0026-4806.22.07972-1
   PubMed Web of Science ®Google Scholar
• Lu JY, Sadri N, Schneider RJ. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev. 2006;20(22):3174–3184. DOI:10.1101/gad.1467606
   PubMed Web of Science ®Google Scholar
• Hitti E, Bakheet T, Al-Souhibani N, et al. Systematic analysis of AU-Rich element expression in cancer reveals common functional clusters regulated by key RNA-Binding proteins. Cancer Res. 2016;76(14):4068–4080. DOI:10.1158/0008-5472.CAN-15-3110
   PubMed Web of Science ®Google Scholar
• Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol. 2010;10(1):24–35. DOI:10.1038/nri2685
   PubMed Web of Science ®Google Scholar
• Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15(12):829–845. DOI:10.1038/nrg3813
   PubMed Web of Science ®Google Scholar
• Keller A, Fehlmann T, Ludwig N, et al. Genome-wide MicroRNA expression profiles in COPD: Early predictors for cancer development. Genomics Proteomics Bioinformatics. 2018;16(3):162–171. DOI:10.1016/j.gpb.2018.06.001
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Hobbs BD, Hersh CP, et al. Identifying miRNA-mRNA networks associated with COPD phenotypes. Front Genet. 2021;12:748356.
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Kuwano Y, Kim HH, et al. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem. 2008;389(3):243–255. DOI:10.1515/BC.2008.022
   PubMed Web of Science ®Google Scholar
• Wang Z, Bhattacharya A, Ivanov DN. Identification of Small-Molecule inhibitors of the HuR/RNA interaction using a fluorescence polarization screening assay followed by NMR validation. PLoS One. 2015;10(9):e0138780.
   PubMed Web of Science ®Google Scholar
• Patial S, Blackshear PJ. Tristetraprolin as a therapeutic target in inflammatory disease. Trends Pharmacol Sci. 2016;37(10):811–821. DOI:10.1016/j.tips.2016.07.002
   PubMed Web of Science ®Google Scholar
• Hong S. RNA binding protein as an emerging therapeutic target for cancer prevention and treatment. J Cancer Prev. 2017;22(4):203–210. DOI:10.15430/JCP.2017.22.4.203
   PubMedGoogle Scholar
• Caramori G, Ruggeri P, Mumby S, et al. Molecular links between COPD and lung cancer: new targets for drug discovery? Expert Opin Ther Targets. 2019;23(6):539–553. DOI:10.1080/14728222.2019.1615884
   PubMed Web of Science ®Google Scholar
• Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008;452(7187):633–637. DOI:10.1038/nature06885
   PubMed Web of Science ®Google Scholar
• Pillai SG, Ge D, Zhu G, ICGN Investigators, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 2009;5(3):e1000421.
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Whittington CF, et al. Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after Sub-phenotyping for COPD. PLoS One. 2011;6(2):e16476.
   PubMed Web of Science ®Google Scholar
• Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016;42:63–71. DOI:10.1016/j.dnarep.2016.04.008
   PubMed Web of Science ®Google Scholar
• Choi YY, Kang HK, Choi JE, et al. Comprehensive assessment of P21 polymorphisms and lung cancer risk. J Hum Genet. 2008;53(1):87–95. DOI:10.1007/s10038-007-0222-6
   PubMed Web of Science ®Google Scholar
• Lee YL, Chen W, Tsai WK, et al. Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease. J Lab Clin Med. 2006;147(5):228–233. DOI:10.1016/j.lab.2005.12.008
   PubMed Web of Science ®Google Scholar
• Caramori G, Adcock IM, Casolari P, et al. Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax. 2011;66(6):521–527. DOI:10.1136/thx.2010.156448
   PubMed Web of Science ®Google Scholar
• Meek K, Gupta S, Ramsden DA, et al. The DNA-dependent protein kinase: the director at the end. Immunol Rev. 2004;200:132–141. DOI:10.1111/j.0105-2896.2004.00162.x
   PubMed Web of Science ®Google Scholar
• Pramanik S, Roychoudhury S, Bhakat KK. Oxidized DNA base damage repair and transcription. In Chakraborti S., Ray B.K., Roychoudhury S. (eds) Handbook of oxidative stress in cancer: Mechanistic aspects. Springer, Singapore. 2022. 1621–1637.
   Google Scholar
• Chowdhury A. Glutathione peroxidase and lung cancer: an unravel story. In Chakraborti S., Ray B.K., Roychoudhury S. (eds) Handbook of oxidative stress in cancer: Mechanistic aspects. Springer, Singapore. 2022. 1481–1491.
   Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. DOI:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Li P, Wang Y, Wang X, et al. Identification of susceptible genes for chronic obstructive pulmonary disease with lung adenocarcinoma by weighted gene Co-Expression network analysis. Onco Targets Ther. 2021;14:3625–3634. DOI:10.2147/OTT.S303544
   PubMed Web of Science ®Google Scholar
• Eguren M, Manchado E, Malumbres M. Non-mitotic functions of the Anaphase-Promoting complex. Semin Cell Dev Biol. 2011;22(6):572–578. DOI:10.1016/j.semcdb.2011.03.010
   PubMed Web of Science ®Google Scholar
• Lafranchi L, de Boer HR, de Vries EG, et al. APC/C(Cdh1) controls CtIP stability during the cell cycle and in response to DNA damage. Embo J. 2014;33(23):2860–2879. DOI:10.15252/embj.201489017
   PubMed Web of Science ®Google Scholar
• Crawford LJ, Anderson G, Johnston CK, et al. Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma. Oncotarget. 2016;7(43):70481–70493. DOI:10.18632/oncotarget.12026
   PubMedGoogle Scholar
• Wan L, Chen M, Cao J, et al. The APC/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function. Cancer Discov. 2017;7(4):424–441. DOI:10.1158/2159-8290.CD-16-0647
   PubMed Web of Science ®Google Scholar
• Miao TW, Xiao W, Du LY, et al. High expression of SPP1 in patients with chronic obstructive pulmonary disease (COPD) is correlated with increased risk of lung cancer. FEBS Open Bio. 2021;11(4):1237–1249. DOI:10.1002/2211-5463.13127
   PubMed Web of Science ®Google Scholar
• Hu Z, Lin D, Yuan J, et al. Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer. Clin Cancer Res. 2005;11(13):4646–4652. DOI:10.1158/1078-0432.CCR-04-2013
   PubMed Web of Science ®Google Scholar
• Ali MN, Mori M, Mertens TCJ, et al. Osteopontin expression in small airway epithelium in copd is dependent on differentiation and confined to subsets of cells. Sci Rep. 2019;9(1):15566. DOI:10.1038/s41598-019-52208-3
   PubMedGoogle Scholar
• Boelens MC, Gustafson AM, Postma DS, et al. A chronic obstructive pulmonary disease related signature in squamous cell lung cancer. Lung Cancer. 2011;72(2):177–183. DOI:10.1016/j.lungcan.2010.08.014
   PubMed Web of Science ®Google Scholar
• Lamontagne M, Bérubé JC, Obeidat M, International COPD Genetics Consortium, et al. Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations. Hum Mol Genet. 2018;27(10):1819–1829. DOI:10.1093/hmg/ddy091
   PubMed Web of Science ®Google Scholar
• Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer. 2013;13(4):233–245. DOI:10.1038/nrc3477
   PubMed Web of Science ®Google Scholar
• Berg J, Halvorsen AR, Bengtson MB, et al. Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. BMC Cancer. 2018;18(1):739. DOI:10.1186/s12885-018-4659-0
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. DOI:10.1016/j.jaci.2016.05.011
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory endotypes in COPD. Allergy. 2019;74(7):1249–1256. DOI:10.1111/all.13760
   PubMed Web of Science ®Google Scholar
• Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584–596. DOI:10.1038/nrclinonc.2015.105
   PubMed Web of Science ®Google Scholar
• Tessema M, Yingling CM, Picchi MA, et al. Epigenetic repression of CCDC37 and MAP1B links chronic obstructive pulmonary disease to lung cancer. J Thorac Oncol. 2015;10(8):1181–1188. DOI:10.1097/JTO.0000000000000592
   PubMed Web of Science ®Google Scholar
• Yamamoto R, Song K, Yanagisawa HA, et al. The MIA complex is a conserved and novel dynein regulator essential for normal ciliary motility. J Cell Biol. 2013;201(2):263–278. DOI:10.1083/jcb.201211048
   PubMed Web of Science ®Google Scholar
• Kwon YJ, Lee SJ, Koh JS, et al. Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol. 2012;7(1):20–33. DOI:10.1097/JTO.0b013e3182307f62
   PubMed Web of Science ®Google Scholar
• Li L, Yan S, Zhang H, et al. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. BMC Cancer. 2019;19(1):894. DOI:10.1186/s12885-019-6119-x
   PubMed Web of Science ®Google Scholar
• Wauters E, Janssens W, Vansteenkiste J, et al. DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature. Thorax. 2015;70(12):1113–1122. DOI:10.1136/thoraxjnl-2015-207288
   PubMed Web of Science ®Google Scholar
• Schotten LM, Darwiche K, Seweryn M, et al. DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients. Eur J Cancer. 2021;147:142–150. DOI:10.1016/j.ejca.2021.01.032
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. DOI:10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. DOI:10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. DOI:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–771. DOI:10.1038/nrc3611
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Baker J, Donnelly LE. Cellular senescence as a mechanism and target in chronic lung diseases. Am J Respir Crit Care Med. 2019;200(5):556–564. DOI:10.1164/rccm.201810-1975TR
   PubMed Web of Science ®Google Scholar
• Kumar M, Seeger W, Voswinckel R. Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2014;51(3):323–333. DOI:10.1165/rcmb.2013-0382PS
   PubMed Web of Science ®Google Scholar
• Agustí A, Hogg JC. Update on the pathogenesis of chronic obstructive pulmonary disease. N Engl J Med. 2019;381(13):1248–1256. DOI:10.1056/NEJMra1900475
   PubMed Web of Science ®Google Scholar
• Yang J, Liu M, Hong D, et al. The paradoxical role of cellular senescence in cancer. Front Cell Dev Biol. 2021;9:722205.
   PubMed Web of Science ®Google Scholar
• Laberge RM, Awad P, Campisi J, et al. Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron. 2012;5(1):39–44. DOI:10.1007/s12307-011-0069-4
   PubMedGoogle Scholar
• Mahmood MQ, Shukla SD, Ward C, et al. The underappreciated role of epithelial mesenchymal transition in chronic obstructive pulmonary disease and its strong link to lung cancer. Biomolecules. 2021;11(9):1394. DOI:10.3390/biom11091394
   PubMed Web of Science ®Google Scholar
• Hornung V, Ablasser A, Charrel-Dennis M, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458(7237):514–518. DOI:10.1038/nature07725
   PubMed Web of Science ®Google Scholar
• Colarusso C, Terlizzi M, Lamort AS, et al. Caspase-11 and AIM2 inflammasome are involved in smoking-induced COPD and lung adenocarcinoma. Oncotarget. 2021;12(11):1057–1071. DOI:10.18632/oncotarget.27964
   PubMedGoogle Scholar
• Bulgakova O, Kausbekova A, Kussainova A, et al. Involvement of circulating Cell-Free mitochondrial DNA and proinflammatory cytokines in pathogenesis of chronic obstructive pulmonary disease and lung cancer. Asian Pac J Cancer Prev. 2021;22(6):1927–1933. DOI:10.31557/APJCP.2021.22.6.1927
   PubMedGoogle Scholar
• Nam HS, Izumchenko E, Dasgupta S, et al. Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now? Biomark Med. 2017;11(6):475–489. DOI:10.2217/bmm-2016-0373
   PubMed Web of Science ®Google Scholar
• Polverino F, Mirra D, Esposito R, et al. Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer. PREPRINT (Version 1) available at Research Square 2022. DOI:10.21203/rs.3.rs-1375680/v1
   Google Scholar
• Liu S, Zhan Y, Luo J, et al. Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer. Biomed Pharmacother. 2019;111:338–346. DOI:10.1016/j.biopha.2018.12.088
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228. DOI:10.1038/nrm.2017.125
   PubMed Web of Science ®Google Scholar
• Liu Z, Yan J, Tong L, et al. The role of exosomes from BALF in lung disease. J Cell Physiol. 2022;237(1):161–168. DOI:10.1002/jcp.30553
   PubMed Web of Science ®Google Scholar
• O’Farrell HE, Bowman RV, Fong KM, et al. Plasma extracellular vesicle miRNAs can identify lung cancer, current smoking status, and stable COPD. Int J Mol Sci. 2021;22(11):5803. DOI:10.3390/ijms22115803
   PubMed Web of Science ®Google Scholar
• Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet. 2007;8(7):533–543. DOI:10.1038/nrg2111
   PubMed Web of Science ®Google Scholar
• Lunde BM, Moore C, Varani G. RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol. 2007;8(6):479–490. DOI:10.1038/nrm2178
   PubMed Web of Science ®Google Scholar
• Ray D, Kazan H, Cook KB, et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature. 2013;499(7457):172–177. DOI:10.1038/nature12311
   PubMed Web of Science ®Google Scholar
• Corley M, Burns MC, Yeo GW. How RNA-Binding proteins interact with RNA: Molecules and mechanisms. Mol Cell. 2020;78(1):9–29. DOI:10.1016/j.molcel.2020.03.011
   PubMed Web of Science ®Google Scholar
• Coppin L, Leclerc J, Vincent A, et al. Messenger RNA Life-Cycle in cancer cells: Emerging role of conventional and Non-Conventional RNA-Binding proteins? Int J Mol Sci. 2018;19(3):650. DOI:10.3390/ijms19030650
   PubMed Web of Science ®Google Scholar
• Dassi E. Handshakes and fights: the regulatory interplay of RNA-Binding proteins. Front Mol Biosci. 2017;4:67.
   PubMed Web of Science ®Google Scholar
• Benoit Bouvrette LP, Bovaird S, Blanchette M, et al. oRNAment: a database of putative RNA binding protein target sites in the transcriptomes of model species. Nucleic Acids Res. 2020;48(D1):D166–d173.
   PubMed Web of Science ®Google Scholar
• Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci. 1995;20(11):465–470. DOI:10.1016/S0968-0004(00)89102-1
   PubMed Web of Science ®Google Scholar
• Zubiaga AM, Belasco JG, Greenberg ME. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol. 1995;15(4):2219–2230. DOI:10.1128/MCB.15.4.2219
   PubMed Web of Science ®Google Scholar
• Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 2005;33(22):7138–7150. DOI:10.1093/nar/gki1012
   PubMed Web of Science ®Google Scholar
• Raineri I, Wegmueller D, Gross B, et al. Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference. Nucleic Acids Res. 2004;32(4):1279–1288. DOI:10.1093/nar/gkh282
   PubMed Web of Science ®Google Scholar
• Srikantan S, Gorospe M. HuR function in disease. Front Biosci (Landmark Ed). 2012;17(1):189–205. DOI:10.2741/3921
   PubMed Web of Science ®Google Scholar
• Tiedje C, Diaz-Muñoz MD, Trulley P, et al. The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation. Nucleic Acids Res. 2016;44(15):7418–7440. DOI:10.1093/nar/gkw474
   PubMed Web of Science ®Google Scholar
• Piecyk M, Wax S, Beck AR, et al. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. Embo J. 2000;19(15):4154–4163. DOI:10.1093/emboj/19.15.4154
   PubMed Web of Science ®Google Scholar
• García-Mauriño SM, Rivero-Rodríguez F, Velázquez-Cruz A, et al. RNA binding protein regulation and Cross-Talk in the control of AU-rich mRNA fate. Front Mol Biosci. 2017;4:71.
   PubMed Web of Science ®Google Scholar
• Moore AE, Chenette DM, Larkin LC, et al. Physiological networks and disease functions of RNA-binding protein AUF1. Wiley Interdiscip Rev RNA. 2014;5(4):549–564. DOI:10.1002/wrna.1230
   PubMed Web of Science ®Google Scholar
• Lee EK. Post-translational modifications of RNA-binding proteins and their roles in RNA granules. Curr Protein Pept Sci. 2012;13(4):331–336.
   PubMed Web of Science ®Google Scholar
• Cao H, Deterding LJ, Blackshear PJ. Identification of a major phosphopeptide in human tristetraprolin by phosphopeptide mapping and mass spectrometry. PLoS One. 2014;9(7):e100977. DOI:10.1371/journal.pone.0100977
   PubMed Web of Science ®Google Scholar
• Coelho MA, de Carné Trécesson S, Rana S, et al. Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA. Immunity. 2017;47(6):1083–1099.e6.
   PubMed Web of Science ®Google Scholar
• Roignant JY, Soller M. m(6)a in mRNA: an ancient mechanism for Fine-Tuning gene expression. Trends Genet. 2017;33(6):380–390. DOI:10.1016/j.tig.2017.04.003
   PubMed Web of Science ®Google Scholar
• Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 2017;27(5):626–641. DOI:10.1038/cr.2017.31
   PubMed Web of Science ®Google Scholar
• Wei CM, Gershowitz A, Moss B. Methylated nucleotides block 5’ terminus of HeLa cell messenger RNA. Cell. 1975;4(4):379–386. DOI:10.1016/0092-8674(75)90158-0
   PubMed Web of Science ®Google Scholar
• Wang S, Sun C, Li J, et al. Roles of rna methylation by means of N(6)-methyladenosine (m(6)A) in human cancers. Cancer Lett. 2017;408:112–120. DOI:10.1016/j.canlet.2017.08.030
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest. 2009;135(1):173–180. DOI:10.1378/chest.08-1419
   PubMed Web of Science ®Google Scholar
• Fulop T, Larbi A, Dupuis G, et al. Immunosenescence and Inflamm-Aging as two sides of the same coin: Friends or foes? Front Immunol. 2017;8:1960. DOI:10.3389/fimmu.2017.01960
   PubMed Web of Science ®Google Scholar
• Anderson P. Post-transcriptional control of cytokine production. Nat Immunol. 2008;9(4):353–359. DOI:10.1038/ni1584
   PubMed Web of Science ®Google Scholar
• Hamilton T, Novotny M, Pavicic PJ, Jr., et al. Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression. Cytokine. 2010;52(1-2):116–122. DOI:10.1016/j.cyto.2010.04.003
   PubMed Web of Science ®Google Scholar
• Yoon JH, De S, Srikantan S, et al. PAR-CLIP analysis uncovers AUF1 impact on target RNA fate and genome integrity. Nat Commun. 2014;5:5248. DOI:10.1038/ncomms6248
   PubMed Web of Science ®Google Scholar
• Herranz N, Gallage S, Mellone M, et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol. 2015;17(9):1205–1217. DOI:10.1038/ncb3225
   PubMed Web of Science ®Google Scholar
• Maitra S, Chou CF, Luber CA, et al. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA. 2008;14(5):950–959. DOI:10.1261/rna.983708
   PubMed Web of Science ®Google Scholar
• White EJ, Brewer G, Wilson GM. Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation. Biochim Biophys Acta. 2013;1829(6-7):680–688. DOI:10.1016/j.bbagrm.2012.12.002
   PubMed Web of Science ®Google Scholar
• Fu D, Collins K. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell. 2007;28(5):773–785. DOI:10.1016/j.molcel.2007.09.023
   PubMed Web of Science ®Google Scholar
• Skerrett-Byrne DA, Bromfield EG, Murray HC, et al. Time-resolved proteomic profiling of cigarette smoke-induced experimental chronic obstructive pulmonary disease. Respirology. 2021;26(10):960–973. DOI:10.1111/resp.14111
   PubMed Web of Science ®Google Scholar
• Bhattacharyya SN, Habermacher R, Martine U, et al. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell. 2006;125(6):1111–1124. DOI:10.1016/j.cell.2006.04.031
   PubMed Web of Science ®Google Scholar
• Iadevaia V, Gerber AP. Combinatorial control of mRNA fates by RNA-Binding proteins and Non-Coding RNAs. Biomolecules. 2015;5(4):2207–2222. DOI:10.3390/biom5042207
   PubMed Web of Science ®Google Scholar
• Guo J, Wang H, Jiang S, et al. The cross-talk between tristetraprolin and cytokines in cancer. Anticancer Agents Med Chem. 2017;17(11):1477–1486.
   PubMed Web of Science ®Google Scholar
• Panganiban RP, Vonakis BM, Ishmael FT, et al. Coordinated post-transcriptional regulation of the chemokine system: messages from CCL2. J Interferon Cytokine Res. 2014;34(4):255–266. DOI:10.1089/jir.2013.0149
   PubMed Web of Science ®Google Scholar
• Wang H, Ding N, Guo J, et al. Dysregulation of TTP and HuR plays an important role in cancers. Tumour Biol. 2016;37(11):14451–14461. DOI:10.1007/s13277-016-5397-z
   PubMedGoogle Scholar
• Wang H, Chen Y, Guo J, et al. Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1. Sci Rep. 2018;8(1):7080. DOI:10.1038/s41598-018-25443-3
   PubMedGoogle Scholar
• Young LE, Sanduja S, Bemis-Standoli K, et al. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during Colon carcinogenesis. Gastroenterology. 2009;136(5):1669–1679. DOI:10.1053/j.gastro.2009.01.010
   PubMed Web of Science ®Google Scholar
• Lafzi A, Kazan H. Inferring RBP-Mediated regulation in lung squamous cell carcinoma. PLoS One. 2016;11(5):e0155354.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang B, Bi J, et al. Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer. Med Oncol. 2011;28 Suppl 1:S577–S85.
   PubMed Web of Science ®Google Scholar
• Dong F, Li C, Wang P, et al. The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells. Exp Cell Res. 2018;367(1):89–96. DOI:10.1016/j.yexcr.2018.03.028
   PubMed Web of Science ®Google Scholar
• Sandri BJ, Kaplan A, Hodgson SW, et al. Multi-omic molecular profiling of lung cancer in COPD. Eur Respir J. 2018;52(1):1702665. DOI:10.1183/13993003.02665-2017
   PubMed Web of Science ®Google Scholar
• Venigalla RK, Turner M. RNA-binding proteins as a point of convergence of the PI3K and p38 MAPK pathways. Front Immunol. 2012;3:398.
   PubMed Web of Science ®Google Scholar
• Harvey RF, Smith TS, Mulroney T, et al. Trans-acting translational regulatory RNA binding proteins. Wiley Interdiscip Rev RNA. 2018;9(3):e1465.
   PubMed Web of Science ®Google Scholar
• Ho JJD, Balukoff NC, Theodoridis PR, et al. A network of RNA-binding proteins controls translation efficiency to activate anaerobic metabolism. Nat Commun. 2020;11(1):2677. DOI:10.1038/s41467-020-16504-1
   PubMed Web of Science ®Google Scholar
• Schneider-Lunitz V, Ruiz-Orera J, Hubner N, et al. Multifunctional RNA-binding proteins influence mRNA abundance and translational efficiency of distinct sets of target genes. PLoS Comput Biol. 2021;17(12):e1009658.
   PubMedGoogle Scholar
• Graham JR, Hendershott MC, Terragni J, et al. mRNA degradation plays a significant role in the program of gene expression regulated by phosphatidylinositol 3-kinase signaling. Mol Cell Biol. 2010;30(22):5295–5305. DOI:10.1128/MCB.00303-10
   PubMed Web of Science ®Google Scholar
• Khabar KS. Hallmarks of cancer and AU-rich elements. Wiley Interdiscip Rev RNA. 2017;8(1):e1368. DOI:10.1002/wrna.1368
   PubMed Web of Science ®Google Scholar
• Sandri BJ, Masvidal L, Murie C, et al. Distinct Cancer-Promoting stromal gene expression depending on lung function. Am J Respir Crit Care Med. 2019;200(3):348–358. DOI:10.1164/rccm.201801-0080OC
   PubMed Web of Science ®Google Scholar
• Blethrow JD, Glavy JS, Morgan DO, et al. Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates. Proc Natl Acad Sci U S A. 2008;105(5):1442–1447. DOI:10.1073/pnas.0708966105
   PubMed Web of Science ®Google Scholar
• Kim HH, Abdelmohsen K, Lal A, et al. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev. 2008;22(13):1804–1815. DOI:10.1101/gad.1645808
   PubMed Web of Science ®Google Scholar
• Juan Y, Haiqiao W, Xie W, et al. Cold-inducible RNA-binding protein mediates airway inflammation and mucus hypersecretion through a post-transcriptional regulatory mechanism under cold stress. Int J Biochem Cell Biol. 2016;78:335–348. DOI:10.1016/j.biocel.2016.07.029
   PubMed Web of Science ®Google Scholar
• Navratilova Z, Novosadova E, Hagemann-Jensen M, et al. Expression profile of six RNA-Binding proteins in pulmonary sarcoidosis. PLoS ONE. 2016;11(8):e0161669. DOI:10.1371/journal.pone.0161669
   PubMed Web of Science ®Google Scholar
• Baker JR, Vuppusetty C, Ito K, et al. RNA-binding protein HuR inhibits the expression of sirtuin-1 in patients with COPD. European Respiraory Journal. 2017;50(suppl 61):OA287.
   Google Scholar
• Ricciardi L, Col JD, Casolari P, et al. Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3173–3190. DOI:10.2147/COPD.S166284
   PubMed Web of Science ®Google Scholar
• Ricciardi L, Giurato G, Memoli D, et al. Posttranscriptional gene regulatory networks in chronic airway inflammatory diseases: in silico mapping of RNA-Binding protein expression in airway epithelium. Front Immunol. 2020;11:579889.
   PubMed Web of Science ®Google Scholar
• O’Brien K, Breyne K, Ughetto S, et al. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 2020;21(10):585–606. DOI:10.1038/s41580-020-0251-y
   PubMed Web of Science ®Google Scholar
• Cianferoni A, Schroeder JT, Kim J, et al. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin. Blood. 2001;97(6):1742–1749. DOI:10.1182/blood.v97.6.1742
   PubMed Web of Science ®Google Scholar
• Yu SY, Ip MS, Li X, et al. Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong: a cohort study. PLoS Med. 2022;19(1):e1003880. DOI:10.1371/journal.pmed.1003880
   PubMed Web of Science ®Google Scholar
• Sengupta S, Jang BC, Wu MT, et al. The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J Biol Chem. 2003;278(27):25227–25233. DOI:10.1074/jbc.M301813200
   PubMed Web of Science ®Google Scholar
• Blanco FF, Preet R, Aguado A, et al. Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis. Oncotarget. 2016;7(45):74043–74058. DOI:10.18632/oncotarget.12189
   PubMedGoogle Scholar
• Zhou L, Gu W, Kui F, et al. The mechanism and candidate compounds of aged citrus peel (chenpi) preventing chronic obstructive pulmonary disease and its progression to lung cancer. Food Nutr Res. 2021;65. DOI:10.29219/fnr.v65.7526
   Web of Science ®Google Scholar
• Ishmael FT, Fang X, Galdiero MR, et al. Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation. J Immunol. 2008;180(12):8342–8353. DOI:10.4049/jimmunol.180.12.8342
   PubMed Web of Science ®Google Scholar
• Patel B, Priefer R. Impact of chronic obstructive pulmonary disease, lung infection, and/or inhaled corticosteroids use on potential risk of lung cancer. Life Sci. 2022;294:120374. DOI:10.1016/j.lfs.2022.120374
   PubMed Web of Science ®Google Scholar
• Voura M, Sflakidou E, Sarli V. Modulators of ROS/NF-κB signaling in cancer therapy. In Chakraborti S., Ray B.K., Roychoudhury S. (eds) Handbook of oxidative stress in cancer: Mechanistic aspects. Springer, Singapore. 2022. 2165–2184.
   Google Scholar
• Youn H, Jeong JC, Jeong YS, et al. Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944–951. DOI:10.1248/bpb.b12-01004
   PubMed Web of Science ®Google Scholar
• Li X, Qu Z, Jing S, et al. Dioscin-60-O-acetate inhibits lung cancer cell proliferation via inducing cell cycle arrest and caspase-dependent apoptosis. Phytomedicine. 2019;53:124–133. DOI:10.1016/j.phymed.2018.09.033
   PubMed Web of Science ®Google Scholar
• Schichl YM, Resch U, Hofer-Warbinek R, et al. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation. J Biol Chem. 2009;284(43):29571–29581. DOI:10.1074/jbc.M109.031237
   PubMed Web of Science ®Google Scholar
• Mohibi S, Chen X, Zhang J. Cancer the’RBP’eutics-RNA-binding proteins as therapeutic targets for cancer. Pharmacol Ther. 2019;203:107390. DOI:10.1016/j.pharmthera.2019.07.001
   PubMed Web of Science ®Google Scholar
• Meisner NC, Hintersteiner M, Mueller K, et al. Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR. Nat Chem Biol. 2007;3(8):508–515. DOI:10.1038/nchembio.2007.14
   PubMed Web of Science ®Google Scholar
• Kondaskar A, Kondaskar S, Kumar R, et al. Novel, broad spectrum anti-Cancer agents containing the tricyclic 5:7:5-Fused diimidazodiazepine ring system. ACS Med Chem Lett. 2010;2(3):252–256. DOI:10.1021/ml100281b
   PubMed Web of Science ®Google Scholar
• Clingman CC, Deveau LM, Hay SA, et al. Allosteric inhibition of a stem cell RNA-binding protein by an intermediary metabolite. Elife. 2014;3:e02848. DOI:10.7554/eLife.02848
   PubMed Web of Science ®Google Scholar
• Amreddy N, Babu A, Panneerselvam J, et al. Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine. 2018;14(2):373–384. DOI:10.1016/j.nano.2017.11.010
   PubMed Web of Science ®Google Scholar
• Muralidharan R, Babu A, Amreddy N, et al. Tumor-targeted nanoparticle delivery of HuR siRNA inhibits lung tumor growth in vitro and in vivo by disrupting the oncogenic activity of the RNA-binding protein HuR. Mol Cancer Ther. 2017;16(8):1470–1486. DOI:10.1158/1535-7163.MCT-17-0134
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. DOI:10.1038/onc.2017.361
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Panda AC, Munk R, et al. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol. 2017;14(3):361–369. DOI:10.1080/15476286.2017.1279788
   PubMed Web of Science ®Google Scholar
• Khabar KS. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J Interferon Cytokine Res. 2005;25(1):1–10. DOI:10.1089/jir.2005.25.1
   PubMed Web of Science ®Google Scholar
• Wang W, Furneaux H, Cheng H, et al. HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol. 2000;20(3):760–769. DOI:10.1128/MCB.20.3.760-769.2000
   PubMed Web of Science ®Google Scholar
• Patino WD, Kang JG, Matoba S, et al. Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin. Circ Res. 2006;98(10):1282–1289. DOI:10.1161/01.RES.0000222284.48288.28
   PubMed Web of Science ®Google Scholar
• Al-Haj L, Blackshear PJ, Khabar KS. Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements. Nucleic Acids Res. 2012;40(16):7739–7752. DOI:10.1093/nar/gks545
   PubMed Web of Science ®Google Scholar
• Pont AR, Sadri N, Hsiao SJ, et al. mRNA decay factor AUF1 maintains normal aging, telomere maintenance, and suppression of senescence by activation of telomerase transcription. Mol Cell. 2012;47(1):5–15. DOI:10.1016/j.molcel.2012.04.019
   PubMed Web of Science ®Google Scholar
• Chang N, Yi J, Guo G, et al. HuR uses AUF1 as a cofactor to promote p16INK4 mRNA decay. Mol Cell Biol. 2010;30(15):3875–3886. DOI:10.1128/MCB.00169-10
   PubMed Web of Science ®Google Scholar
• Pang L, Tian H, Chang N, et al. Loss of CARM1 is linked to reduced HuR function in replicative senescence. BMC Mol Biol. 2013;14(15):15.
   PubMedGoogle Scholar
• Wang W, Martindale JL, Yang X, et al. Increased stability of the p16 mRNA with replicative senescence. EMBO Rep. 2005;6(2):158–164. DOI:10.1038/sj.embor.7400346
   PubMed Web of Science ®Google Scholar
• Zhou H, Jarujaron S, Gurley EC, et al. HIV protease inhibitors increase TNF-alpha and IL-6 expression in macrophages: involvement of the RNA-binding protein HuR. Atherosclerosis. 2007;195(1):e134-43–e143. DOI:10.1016/j.atherosclerosis.2007.04.008
   PubMedGoogle Scholar
• Spooren A, Mestdagh P, Rondou P, et al. IL-1β potently stabilizes IL-6 mRNA in human astrocytes. Biochem Pharmacol. 2011;81(8):1004–1015. DOI:10.1016/j.bcp.2011.01.019
   PubMed Web of Science ®Google Scholar
• Ouhara K, Munenaga S, Kajiya M, et al. The induced RNA-binding protein, HuR, targets 3’-UTR region of IL-6 mRNA and enhances its stabilization in periodontitis. Clin Exp Immunol. 2018;192(3):325–336. DOI:10.1111/cei.13110
   PubMed Web of Science ®Google Scholar
• Patil CS, Liu M, Zhao W, et al. Targeting mRNA stability arrests inflammatory bone loss. Mol Ther. 2008;16(10):1657–1664. DOI:10.1038/mt.2008.163
   PubMed Web of Science ®Google Scholar
• Van Tubergen E, Vander Broek R, Lee J, et al. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma. Cancer. 2011; Jun117(12):2677–2689. DOI:10.1002/cncr.25859
   PubMed Web of Science ®Google Scholar
• Zhao W, Liu M, D’Silva NJ, et al. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3’ untranslated region. J Interferon Cytokine Res. 2011;31(8):629–637. DOI:10.1089/jir.2010.0154
   PubMed Web of Science ®Google Scholar
• Paschoud S, Dogar AM, Kuntz C, et al. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol Cell Biol. 2006;26(22):8228–8241. DOI:10.1128/MCB.01155-06
   PubMed Web of Science ®Google Scholar
• Dean JL, Wait R, Mahtani KR, et al. The 3’ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol. 2001;21(3):721–730. DOI:10.1128/MCB.21.3.721-730.2001
   PubMed Web of Science ®Google Scholar
• Deleault KM, Skinner SJ, Brooks SA. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol. 2008;45(1):13–24. DOI:10.1016/j.molimm.2007.05.017
   PubMed Web of Science ®Google Scholar
• Sadri N, Schneider RJ. Auf1/hnrnpd-deficient mice develop pruritic inflammatory skin disease. J Invest Dermatol. 2009;129(3):657–670. DOI:10.1038/jid.2008.298
   PubMed Web of Science ®Google Scholar
• Li M, Yang J, Liu K, et al. p16 promotes proliferation in cervical carcinoma cells through CDK6-HuR-IL1A axis. J Cancer. 2020;11(6):1457–1467. DOI:10.7150/jca.35479
   PubMed Web of Science ®Google Scholar
• Sneezum L, Eislmayr K, Dworak H, et al. Context-Dependent IL-1 mRNA-Destabilization by TTP prevents dysregulation of immune homeostasis under steady state conditions. Front Immunol. 2020;11:1398.
   PubMed Web of Science ®Google Scholar
• Chen YL, Huang YL, Lin NY, et al. Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem Biophys Res Commun. 2006;346(1):160–168. DOI:10.1016/j.bbrc.2006.05.093
   PubMed Web of Science ®Google Scholar
• Fan J, Ishmael FT, Fang X, et al. Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Immunol. 2011;186(4):2482–2494. DOI:10.4049/jimmunol.0903634
   PubMed Web of Science ®Google Scholar
• Hintzen C, Haan C, Tuckermann JP, et al. Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8, chemokine expression. J Immunol. 2008;181(10):7341–7349. DOI:10.4049/jimmunol.181.10.7341
   PubMed Web of Science ®Google Scholar
• Datta S, Biswas R, Novotny M, et al. Tristetraprolin regulates CXCL1 (KC) mRNA stability. J Immunol. 2008;180(4):2545–2552. DOI:10.4049/jimmunol.180.4.2545
   PubMed Web of Science ®Google Scholar
• Qiu LQ, Lai WS, Bradbury A, et al. Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli. J Leukoc Biol. 2015;97(4):723–736. DOI:10.1189/jlb.3A0214-106R
   PubMed Web of Science ®Google Scholar
• Kratochvill F, Machacek C, Vogl C, et al. Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation. Mol Syst Biol. 2011;7:560. DOI:10.1038/msb.2011.93
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang J, Zhang Y, et al. Nitric oxide-p38 MAPK signaling stabilizes mRNA through AU-rich element-dependent and -independent mechanisms. J Leukoc Biol. 2008;83(4):982–990. DOI:10.1189/jlb.0907641
   PubMed Web of Science ®Google Scholar
• Hudy MH, Proud D. Cigarette smoke enhances human rhinovirus-induced CXCL8 production via HuR-mediated mRNA stabilization in human airway epithelial cells. Respir Res. 2013;14(1):88. DOI:10.1186/1465-9921-14-88
   PubMedGoogle Scholar
• Suswam E, Li Y, Zhang X, et al. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res. 2008;68(3):674–682. DOI:10.1158/0008-5472.CAN-07-2751
   PubMed Web of Science ®Google Scholar
• Bourcier C, Griseri P, Grépin R, et al. Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells. Am J Physiol Cell Physiol. 2011;301(3):C609–18. DOI:10.1152/ajpcell.00506.2010
   PubMed Web of Science ®Google Scholar
• Jimbo M, Blanco FF, Huang YH, et al. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget. 2015;6(29):27312–27331. DOI:10.18632/oncotarget.4743
   PubMedGoogle Scholar
• Liu H, Lan T, Li H, et al. Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR. Theranostics. 2021;11(3):1396–1411. DOI:10.7150/thno.53227
   PubMed Web of Science ®Google Scholar
• Akool el S, Kleinert H, Hamada FM, et al. Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol Cell Biol. 2003;23(14):4901–4916. DOI:10.1128/MCB.23.14.4901-4916.2003
   PubMed Web of Science ®Google Scholar
• Van Tubergen EA, Banerjee R, Liu M, et al. Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6. Clin Cancer Res. 2013;19(5):1169–1179. DOI:10.1158/1078-0432.CCR-12-2927
   PubMed Web of Science ®Google Scholar
• Chenette DM, Cadwallader AB, Antwine TL, et al. Targeted mRNA decay by RNA binding protein AUF1 regulates adult muscle stem cell fate, promoting skeletal muscle integrity. Cell Rep. 2016;16(5):1379–1390. DOI:10.1016/j.celrep.2016.06.095
   PubMed Web of Science ®Google Scholar
• Yiakouvaki A, Dimitriou M, Karakasiliotis I, et al. Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis. J Clin Invest. 2012;122(1):48–61. DOI:10.1172/JCI45021
   PubMed Web of Science ®Google Scholar
• Brennan SE, Kuwano Y, Alkharouf N, et al. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res. 2009;69(12):5168–5176. DOI:10.1158/0008-5472.CAN-08-4238
   PubMed Web of Science ®Google Scholar
• Fellows A, Griffin ME, Petrella BL, et al. AUF1/hnRNP D represses expression of VEGF in macrophages. Mol Biol Cell. 2012;23(8):1414–1422. DOI:10.1091/mbc.E11-06-0545
   PubMed Web of Science ®Google Scholar
• Doller A, Gauer S, Sobkowiak E, et al. Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R. Am J Pathol. 2009;174(4):1252–1263. DOI:10.2353/ajpath.2009.080652
   PubMed Web of Science ®Google Scholar
• Yu H, Stasinopoulos S, Leedman P, et al. Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin. J Biol Chem. 2003;278(16):13912–13918. DOI:10.1074/jbc.M213027200
   PubMed Web of Science ®Google Scholar